Northern Trust Corp Global Blood Therapeutics, Inc. Transaction History

Northern Trust Corp

$600 Billion
Q3 2024

22 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 14, 2022	BUY	$32.4 - $68.18 $280,162 - $589,552	8,647 Added 1.51%	583,069 $39.7 Million
Q2 2022 Aug 12, 2022	SELL	$22.3 - $37.39 $267,042 - $447,745	-11,975 Reduced 2.04%	574,422 $18.4 Million
Q1 2022 May 13, 2022	SELL	$25.68 - $35.59 $587,584 - $814,334	-22,881 Reduced 3.76%	586,397 $20.3 Million
Q4 2021 Feb 08, 2022	BUY	$24.9 - $40.26 $127,363 - $205,929	5,115 Added 0.85%	609,278 $17.8 Million
Q3 2021 Nov 15, 2021	SELL	$25.48 - $37.34 $767,330 - $1.12 Million	-30,115 Reduced 4.75%	604,163 $15.4 Million
Q2 2021 Aug 13, 2021	BUY	$32.46 - $43.42 $10.9 Million - $14.6 Million	336,306 Added 112.86%	634,278 $22.2 Million
Q1 2021 May 12, 2021	BUY	$38.94 - $50.85 $90,691 - $118,429	2,329 Added 0.79%	297,972 $12.1 Million
Q4 2020 Feb 11, 2021	SELL	$37.65 - $63.77 $72,739 - $123,203	-1,932 Reduced 0.65%	295,643 $12.8 Million
Q3 2020 Nov 16, 2020	SELL	$52.76 - $74.49 $542,056 - $765,310	-10,274 Reduced 3.34%	297,575 $16.4 Million
Q2 2020 Aug 14, 2020	SELL	$48.73 - $81.82 $19.4 Million - $32.7 Million	-399,107 Reduced 56.45%	307,849 $19.4 Million
Q1 2020 May 14, 2020	BUY	$41.72 - $87.2 $385,743 - $806,251	9,246 Added 1.33%	706,956 $36.1 Million
Q4 2019 Feb 14, 2020	SELL	$45.7 - $81.86 $1.04 Million - $1.85 Million	-22,655 Reduced 3.14%	697,710 $55.5 Million
Q3 2019 Nov 13, 2019	BUY	$45.35 - $57.91 $2.96 Million - $3.79 Million	65,380 Added 9.98%	720,365 $35 Million
Q2 2019 Aug 13, 2019	BUY	$52.6 - $63.29 $389,345 - $468,472	7,402 Added 1.14%	654,985 $34.5 Million
Q1 2019 May 13, 2019	BUY	$39.99 - $53.48 $1.42 Million - $1.9 Million	35,447 Added 5.79%	647,583 $34.3 Million
Q4 2018 Feb 12, 2019	SELL	$31.54 - $46.67 $299,093 - $442,571	-9,483 Reduced 1.53%	612,136 $25.1 Million
Q3 2018 Nov 14, 2018	BUY	$38.0 - $51.1 $719,340 - $967,323	18,930 Added 3.14%	621,619 $23.6 Million
Q2 2018 Sep 18, 2018	SELL	$38.7 - $50.15 $101,626 - $131,693	-2,626 Reduced 0.43%	602,689 $27.2 Million
Q2 2018 Aug 14, 2018	BUY	$38.7 - $50.15 $4.79 Million - $6.2 Million	123,669 Added 25.68%	605,315 $27.4 Million
Q1 2018 May 09, 2018	BUY	$39.6 - $65.9 $1.49 Million - $2.49 Million	37,751 Added 8.5%	481,646 $23.3 Million
Q4 2017 Feb 14, 2018	SELL	$29.7 - $45.7 $331,244 - $509,692	-11,153 Reduced 2.45%	443,895 $17.5 Million
Q3 2017 Nov 13, 2017	BUY	$25.1 - $31.05 $11.4 Million - $14.1 Million	455,048	455,048 $14.1 Million

Others Institutions Holding GBT

# of Institutions

Shares Held

288K

Call Options Held

Put Options Held

View Full List

About Global Blood Therapeutics, Inc.

Ticker GBT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 67,476,200
Market Cap $4.62B
Description
Global Blood Therapeutics, Inc., a biopharmaceutical company, engages in the discovery, development, and delivery of treatments for underserved patient communities with sickle cell disease (SCD). The company offers Oxbryta tablets, an oral, once-daily therapy for SCD. It also evaluates the safety and pharmacokinetics of single and multiple doses...

More about GBT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Northern Trust Corp, based on Form 13F filings with the SEC.

News

Stay updated on Northern Trust Corp with notifications on news.

Account